However, if factors such as the prescribed medications are negatively impacting B12 status then the frequency may well need to be increased to either 6-monthly or 3-monthly

Sean Wharton, leader of the Wharton Medical Clinic for Weight and Diabetes Management in Ontario, Canada.Researchers tested the triple-dose of semaglutide in two clinical trials, one involving people with obesity and the other in people with obesity and type 2 diabetes.In both trials, participants were randomly assigned to receive either placebo injections or injections of 2.4 mg or 7.4 mg of semaglutide for 72 weeks.In adults without diabetes, a 7.2 mg dose of semaglutide caused an average weight loss of nearly 19%, surpassing the 16% seen with the 2.4 mg dose and 4% with placebo.Nearly half of the people on the higher dose lost 20% or more of their body weight, with one-third losing at least 25%, researchers reported.Adults with type 2 diabetes had similar results 13% weight loss on the heavier dose versus 10% on the lighter dose and 4% with placebo.Participants on the higher dose also achieved trimmer waistlines and lower blood pressure, blood sugar and cholesterol, results showed.Both trials also reported that the higher dose of semaglutide was safe and generally well tolerated

Reputable peptide vendors publish COAs with lot numbers that match the labels on the vials they ship
For that reason, a clinician sets the dose and monitoring plan for each woman individually
NOTE: If you have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications, consult your healthcare professional before using this product
Many are taking both